BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 790746)

  • 21. [Anticholinergic treatment in the therapy of primary enuresis. Effectiveness of oxybutynin chloride in a controlled clinical study of 58 patients].
    Marconi AM; Felici E; Roggia A; Torelli F
    Pediatr Med Chir; 1985; 7(4):573-6. PubMed ID: 3915547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anticholinergic effects of dicyclomine hydrochloride in uninhibited neurogenic bladder dysfunction.
    Fischer CP; Diokno A; Lapides J
    J Urol; 1978 Sep; 120(3):328-9. PubMed ID: 682250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic bladder hyperactivity treated with Ditropan (oxybutynin chloride).
    Nagy F; Hamvas A; Frang D
    Int Urol Nephrol; 1990; 22(6):519-24. PubMed ID: 2093692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of oxybutynin chloride on bladder spasm following transurethral surgery.
    Wein AJ; Hanno PM; Raezer DM; Benson GS
    Urology; 1978 Aug; 12(2):184-6. PubMed ID: 358527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of action of imipramine (tofranil) and propantheline (probanthine) on detrusor contraction.
    Diokno AC; Hyndman CW; Hardy DA; Lapides J
    J Urol; 1972 Jan; 107(1):42-3. PubMed ID: 5058038
    [No Abstract]   [Full Text] [Related]  

  • 26. Symptomatic neurogenic bladder in a cerebral-palsied population.
    McNeal DM; Hawtrey CE; Wolraich ML; Mapel JR
    Dev Med Child Neurol; 1983 Oct; 25(5):612-6. PubMed ID: 6354799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uropharmacology: part VI. Parasympathetic depressants.
    Finkbeiner AE; Bissada NK; Welch LT
    Urology; 1977 Nov; 10(5):503-10. PubMed ID: 21482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of neurogenic bladder dysfunction in the adult.
    Wein AJ; Raezer DM; Benson GS
    Urology; 1976 Nov; 8(5):432-43. PubMed ID: 790744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A benefit-risk assessment of extended-release oxybutynin.
    Michel MC
    Drug Saf; 2002; 25(12):867-76. PubMed ID: 12241127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacology of the neurogenic bladder.
    Pedersen E; Grynderup V
    Acta Neurol Scand; 1966; 42(S20):111-120. PubMed ID: 5328648
    [No Abstract]   [Full Text] [Related]  

  • 32. Oxybutynin in bladder spasm, neurogenic bladder, and enuresis.
    Thompson IM; Lauvetz R
    Urology; 1976 Nov; 8(5):452-4. PubMed ID: 790746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is bethanechol chloride clinically effective in promoting bladder emptying? A literature review.
    Finkbeiner AE
    J Urol; 1985 Sep; 134(3):443-9. PubMed ID: 2863391
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.